[go: up one dir, main page]

FR24C1042I2 - Vaccin à large spectre contre un réovirus aviaire - Google Patents

Vaccin à large spectre contre un réovirus aviaire

Info

Publication number
FR24C1042I2
FR24C1042I2 FR24C1042C FR24C1042C FR24C1042I2 FR 24C1042 I2 FR24C1042 I2 FR 24C1042I2 FR 24C1042 C FR24C1042 C FR 24C1042C FR 24C1042 C FR24C1042 C FR 24C1042C FR 24C1042 I2 FR24C1042 I2 FR 24C1042I2
Authority
FR
France
Prior art keywords
broad
vaccine against
avian reovirus
spectrum vaccine
spectrum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR24C1042C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of FR24C1042I1 publication Critical patent/FR24C1042I1/fr
Application granted granted Critical
Publication of FR24C1042I2 publication Critical patent/FR24C1042I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR24C1042C 2014-10-03 2024-10-31 Vaccin à large spectre contre un réovirus aviaire Active FR24C1042I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14187650 2014-10-03
PCT/EP2015/072810 WO2016050961A1 (fr) 2014-10-03 2015-10-02 Vaccin à large spectre contre le réovirus aviaire

Publications (2)

Publication Number Publication Date
FR24C1042I1 FR24C1042I1 (fr) 2024-12-06
FR24C1042I2 true FR24C1042I2 (fr) 2025-11-07

Family

ID=51663053

Family Applications (1)

Application Number Title Priority Date Filing Date
FR24C1042C Active FR24C1042I2 (fr) 2014-10-03 2024-10-31 Vaccin à large spectre contre un réovirus aviaire

Country Status (10)

Country Link
US (1) US10493147B2 (fr)
EP (1) EP3200820B1 (fr)
CN (1) CN106794242B (fr)
BR (1) BR112017006620B1 (fr)
ES (1) ES2954910T3 (fr)
FR (1) FR24C1042I2 (fr)
HU (3) HUE063529T2 (fr)
PL (1) PL3200820T3 (fr)
RU (1) RU2701808C2 (fr)
WO (1) WO2016050961A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020012428A1 (fr) * 2018-07-13 2020-01-16 Biomune Company Nouveaux vaccins contre les réovirus aviaires
RU2750865C1 (ru) * 2020-04-09 2021-07-05 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук" (ФГБНУ ФНЦ ВИЭВ РАН) Поливалентная инактивированная вакцина против риемереллёза, пастереллёза и сальмонеллёза индеек, уток и гусей, способ её получения
CN113907046A (zh) * 2021-11-09 2022-01-11 福建省连江县刘氏兔业养殖场 一种含特异性转移因子的ty26种兔群的选育方法和相应兔品系的培育方法
CN117659139B (zh) * 2023-11-09 2024-11-08 中国兽医药品监察所 一种检测禽呼肠孤病毒抗体的间接elisa试剂盒

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5525342A (en) 1994-05-20 1996-06-11 Akzo Nobel, N.V. Reovirus strain 2177 and vaccine containing same
DE60019178T2 (de) 1999-01-29 2005-09-08 Akzo Nobel N.V. Neue Antigenklasse von Geflügelreoviren
CA2498768A1 (fr) 2002-10-09 2004-04-22 Akzo Nobel N.V. Methodes de traitement et de prevention de symptomes neurologiques causes par un reovirus aviaire et nouvelles caracteristiques associees
TWI398272B (zh) 2005-03-08 2013-06-11 Intervet Int Bv 化學定義的安定劑
CN1895667B (zh) * 2006-06-06 2010-11-03 瑞普（保定）生物药业有限公司 一种呼肠孤病毒灭活疫苗及制备方法
WO2008076518A2 (fr) * 2006-10-25 2008-06-26 University Of Georgia Research Foundation, Inc. Compositions de réovirus et procédés d'utilisation réovirus
WO2009093251A2 (fr) * 2008-01-24 2009-07-30 Gavish-Galilee Bio Applications Ltd Vaccin contenant un réovirus basé sur une séquence de protéine sigma c
EP2471926A3 (fr) 2010-12-30 2012-07-11 Intervet International BV Oligodésoxynucléotides immunostimulateurs
WO2012160183A1 (fr) 2011-05-26 2012-11-29 Intervet International B.V. Oligodésoxynucléotides immunostimulatoires
EP2714908B1 (fr) 2011-05-26 2018-04-18 Intervet International B.V. Oligodésoxynucléotides immunostimulateurs
CA3040110A1 (fr) * 2015-10-13 2017-04-20 Daniel C. Carter Proteines de fusion nsp10 a auto-assemblage pour vaccins, agents therapeutiques, diagnostics et autres applications de nanomateriaux

Also Published As

Publication number Publication date
CN106794242B (zh) 2021-11-30
BR112017006620B1 (pt) 2023-12-26
EP3200820A1 (fr) 2017-08-09
HUE063529T2 (hu) 2024-01-28
WO2016050961A1 (fr) 2016-04-07
US10493147B2 (en) 2019-12-03
CN106794242A (zh) 2017-05-31
HUS2400031I1 (hu) 2024-10-28
PL3200820T3 (pl) 2023-09-18
RU2701808C2 (ru) 2019-10-01
ES2954910T3 (es) 2023-11-27
RU2017114503A (ru) 2018-11-06
EP3200820B1 (fr) 2023-07-05
US20180326043A1 (en) 2018-11-15
RU2017114503A3 (fr) 2019-04-22
FR24C1042I1 (fr) 2024-12-06
BR112017006620A2 (pt) 2017-12-12
HUS2400032I1 (hu) 2024-10-28

Similar Documents

Publication Publication Date Title
DK3393510T3 (da) Zikavirusvaccine
EP3472281A4 (fr) Événement élite canola ns-b50027-4
DK3220988T3 (da) Intranasal administration
DK3171891T3 (da) Fremgangsmåde
HUE053347T2 (hu) Glikopeptid-készítmények
EP3367938A4 (fr) Implant à autocompression
FR24C1042I2 (fr) Vaccin à large spectre contre un réovirus aviaire
EP3424940A4 (fr) Médicament radiomarqué
DK3188599T3 (da) Medicinske behandlinger baseret på anamorelin
EP3195016C0 (fr) Moniteur de radon
EP3531936A4 (fr) Forceps rétractables
EP3498837A4 (fr) Procédé d'édition de génome
EP3511016A4 (fr) Immunostimulant
EP3562498A4 (fr) Vaccins contre la grippe
DK3405212T3 (da) Cancervacciner
EP3322718C0 (fr) Vaccins anticancéreux histones
DK3155004T3 (da) Vaccine til immunkompromitterede værter
GB201506041D0 (en) Avian vaccine
DK3148513T3 (da) Ceritinib-formulering
EP3099789A4 (fr) Vaccins contre les réovirus aviaires
EP3395344A4 (fr) Médicament
HRP20200115T1 (hr) Medicinski flaster
DK3193856T3 (da) Formulering
IL260988A (en) Ptps-based vaccines against cancer
DK3472739T3 (da) Procedurebakkeadministration